Select your country or region
- Africa
- America
- Asia
- Europe
- Oceania
- Australia
- New Zealand
- Andorra
- Austria
- Czech Republic
- Denmark
- Finland
- France
- Germany
- Gibraltar
- Iceland
- Ireland
- Italy
- Norway
- Poland
- Portugal
- San Marino
- Slovakia
- Spain
- Sweden
- Switzerland
- UK
- Vaticano
- Argentina
- Aruba
- Bolivia
- Brazil
- Canada
- Chile
- Colombia
- Costa Rica
- Curacao
- Dominican Republic
- Ecuador
- El Salvador
- Guatemala
- Honduras
- Mexico
- Nicaragua
- Panama
- Paraguay
- Peru
- Surinam
- Trinidad and Tobago
- USA
- Uruguay
- Venezuela
- Bahrain
- Bangladesh
- Brunei
- Cambodia
- China
- Hong Kong SAR
- India
- Indonesia
- Iraq
- Japan
- Jordan
- Kuwait
- Laos
- Lebanon
- Malaysia
- Oman
- Pakistan
- Philippines
- Qatar
- Saudi Arabia
- Singapore
- South Korea
- Sri Lanka
- Taiwan, China
- Thailand
- UAE
- Vietnam
- Yemen
- Angola
- Cape Verde
- Egypt
- Guinea-Bissau
- Mozambique
- São Tomé and Príncipe
GRIFOLS CANADA Ltd.
Grifols Canada was established in 2011. Based in Mississauga, we cover the Canadian markets.
We offer a comprehensive portfolio of products and services from the Bioscience division, including Gamunex®, IGIVnex®, Prolastin®-C, Plasbumin®, HyperTET®, GamaSTAN®, HyperRAB® and HyperHEP B®. Safety and quality are our top priorities as we deliver on our mission: improving the health and well-being of people around the world.
For information on the products available in your country please click here
5060 Spectrum Way, Suite 405
Mississauga, ON, L4W 5N5
CANADA
Contact information
Tel. 905-614-5575
Toll Free 1-866-482-5226
Fax 905-614-5590
Notification of adverse reactions
To report an adverse drug reaction click here
Do you want to know more about one of the leading healthcare companies? Here you will find all the information about Grifols and our commitment to improving the health and well-being of people around world.